4OTG |
Crystal Structure of PRK1 Catalytic Domain in Complex with Lestaurtinib |
date |
|
authors | Chamberlain, P.P., Delker, S., Pagarigan, B., Mahmoudi, A., Jackson, P., Abbassian, M., Muir, J., Raheja, N., Cathers, B. |
compound |
source |
symmetry | |
|
crystal cell |
length a |
length b |
length c |
angle alpha |
angle beta |
angle gamma |
|
|
|
|
|
|
|
method | X-Ray Diffraction | resolution | 2.60 |
ligand | 2V9, SEP, TPO
| enzyme |
|
Gene Ontology |
Chain | Function | Process | Component | A |
|
|
|
|
Primary reference | Crystal Structures of PRK1 in Complex with the Clinical Compounds Lestaurtinib and Tofacitinib Reveal Ligand Induced Conformational Changes., Chamberlain P, Delker S, Pagarigan B, Mahmoudi A, Jackson P, Abbasian M, Muir J, Raheja N, Cathers B, PLoS One. 2014 Aug 11;9(8):e103638. doi: 10.1371/journal.pone.0103638., eCollection 2014. PMID:25111382 |